Surgery cost-effective but not dominant compared to non-operative treatment for adult scoliosis .
Cost-effectiveness of Operative versus Nonoperative Treatment of Adult Symptomatic Lumbar Scoliosis an Intent-to-treat Analysis at 5-year Follow-up
Spine (Phila Pa 1976). 2019;44(21):1499-1506. 10.1097/BRS.0000000000003118Adult symptomatic lumbar scoliosis is a difficult condition, and it is unclear whether operative or non-operative treatment is ideal. Cost-effectiveness is an important consideration for any intervention. The authors of this study used data from a prior multi-centre RCT to perform a cost-utility analysis with 5-year follow-up. At all time points, the operative group had more quality-adjusted life years gained, but this came at a higher cost. The overall incremental cost-effectiveness ratio was below the $50,000 threshold in years 4 and 5 of the study, but neither treatment was dominant. Thus, both treatments are acceptable in terms of cost and benefit from an economic perspective.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
